From the Research
Spermatoceles are benign cysts that do not require treatment unless they cause significant discomfort or concern, and the most recent and highest quality study recommends microscopic single-tubule spermatocelectomy as a safe and effective treatment option with low complication rates 1. When considering treatment for spermatoceles, it is essential to prioritize the patient's quality of life and minimize the risk of complications.
- The study published in 2025 1 found that microscopic single-tubule spermatocelectomy reduces the risk of epididymal injury and testicular atrophy, with low complication rates and high success rates, particularly in male patients desiring fertility preservation.
- In contrast, earlier studies such as the one published in 2007 2 and 2011 3 reported varying outcomes and complications associated with traditional spermatocelectomy techniques.
- Another study published in 2022 4 explored the use of aspiration and sclerotherapy as a non-surgical alternative for treating hydroceles and spermatoceles, but this approach may not be suitable for all patients. The key factors to consider when evaluating treatment options for spermatoceles include:
- The size and location of the cyst
- The presence of symptoms such as pain or discomfort
- The patient's desire for fertility preservation
- The potential risks and complications associated with each treatment option Ultimately, the decision to treat a spermatocele should be based on a thorough evaluation of the patient's individual needs and circumstances, and microscopic single-tubule spermatocelectomy is a viable option for patients who require surgical intervention 1.